J. Kevin Judice
2022
In 2022, J. Kevin Judice earned a total compensation of $5.8M as Chief Executive Officer at DICE Therapeutics, a 4% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $300,000 |
|---|---|
| Option Awards | $4,933,577 |
| Salary | $540,000 |
| Total | $5,773,577 |
Judice received $4.9M in option awards, accounting for 85% of the total pay in 2022.
Judice also received $300K in non-equity incentive plan and $540K in salary.
Rankings
In 2022, J. Kevin Judice's compensation ranked 535th out of 5,760 executives tracked by ExecPay. In other words, Judice earned more than 90.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 535 out of 5,760 | 91st |
Division Manufacturing | 224 out of 3,136 | 93rd |
Major group Chemicals And Allied Products | 69 out of 1,422 | 95th |
Industry group Drugs | 57 out of 1,323 | 96th |
Industry Pharmaceutical Preparations | 41 out of 969 | 96th |
Source: SEC filing on April 26, 2023.
Judice's colleagues
We found two more compensation records of executives who worked with J. Kevin Judice at DICE Therapeutics in 2022.